A value-oriented fund seeking global invesetments for long-term growth.
Is this fund right for you?
- You want your money to grow over a longer term.
- You want to invest in equities anywhere in the world.
- You're comfortable with a moderate level of risk.
Risk Rating
How is the fund invested?
(as of September 30, 2025)
Asset allocation (%)
|
Name |
Percent |
|
US Equity |
52.6 |
|
International Equity |
44.2 |
|
Cash and Equivalents |
3.3 |
|
Other |
-0.1 |
Geographic allocation (%)
|
Name |
Percent |
|
United States |
52.6 |
|
Ireland |
11.3 |
|
France |
7.6 |
|
Taiwan |
4.2 |
|
Switzerland |
3.6 |
|
Canada |
3.2 |
|
United Kingdom |
2.5 |
|
Denmark |
2.1 |
|
China |
2.0 |
|
Other |
10.9 |
Sector allocation (%)
|
Name |
Percent |
|
Technology |
27.6 |
|
Financial Services |
17.7 |
|
Healthcare |
9.9 |
|
Consumer Goods |
9.7 |
|
Industrial Goods |
9.5 |
|
Consumer Services |
8.1 |
|
Industrial Services |
3.9 |
|
Energy |
3.8 |
|
Cash and Cash Equivalent |
3.3 |
|
Other |
6.5 |
Growth of $10,000
(since inception)
Data not available based on date of inception
Fund details
(as of September 30, 2025)
| Top holdings |
% |
| Alphabet Inc Cl A |
4.6 |
| Microsoft Corp |
4.6 |
| Taiwan Semiconductor Manufactrg Co Ltd - ADR |
4.2 |
| Berkshire Hathaway Inc Cl B |
3.7 |
| Meta Platforms Inc Cl A |
3.4 |
| Cash and Cash Equivalents |
3.2 |
| Booking Holdings Inc |
2.9 |
| Marsh & McLennan Cos Inc |
2.5 |
| Crh PLC |
2.4 |
| Ryanair Holdings PLC - ADR |
2.3 |
| Total allocation in top holdings |
33.8 |
| Portfolio characteristics |
|
| Standard deviation |
10.52% |
| Dividend yield |
1.67% |
| Yield to maturity |
- |
| Duration (years) |
- |
| Coupon |
- |
| Average credit rating |
Not rated |
| Average market cap (million) |
$825,830.1 |
Understanding returns
Annual compound returns (%)
| 1 MO |
3 MO |
YTD |
1 YR |
| {{snapShot.Return1Mth|customNumber:2}} | {{snapShot.Return3Mth|customNumber:2}} | {{snapShot.ReturnYTD|customNumber:2}} | {{snapShot.Return1Yr|customNumber:2}} |
| 3 YR |
5 YR |
10 YR |
INCEPTION |
| {{snapShot.Return3Yr|customNumber:2}} | {{snapShot.Return5Yr|customNumber:2}} | {{snapShot.Return10Yr|customNumber:2}} | {{snapShot.ReturnInception|customNumber:2}} |
Calendar year returns (%)
|
2024 |
2023 |
2022 |
2021 |
| {{snapShot.Return1YrCalendar|customNumber:2}} | {{snapShot.Return2YrCalendar|customNumber:2}} | {{snapShot.Return3YrCalendar|customNumber:2}} | {{snapShot.Return4YrCalendar|customNumber:2}} |
|
2020 |
2019 |
2018 |
2017 |
| {{snapShot.Return5YrCalendar|customNumber:2}} | {{snapShot.Return6YrCalendar|customNumber:2}} | {{snapShot.Return7YrCalendar|customNumber:2}} | {{snapShot.Return8YrCalendar|customNumber:2}} |
Range of returns over five years
(November 1, 2009 - September 30, 2025)
| Best return |
Best period end date |
Worst return |
Worst period end date |
|
16.61% |
May 2017 |
1.00% |
March 2020 |
| Average return |
% of periods with positive returns |
Number of positive periods |
Number of negative periods |
|
8.55% |
100.00% |
132 |
0 |
Q2 2025 Fund Commentary
Market commentary
Global equities declined early in the second quarter of 2025 because of U.S. tariff announcements. However, they later recovered as the U.S. administration paused tariffs. Over the entire quarter, global equities rose 5.7% in Canadian-dollar terms and 11.5% in U.S.-dollar terms.
The U.S. dollar weakened against most other major currencies. The U.S. passed a budget bill that was expected to significantly add to the national debt, which could lead to higher borrowing costs.
Performance
The Fund’s relative exposure to Oracle Corp., Microsoft Corp. and Taiwan Semiconductor Manufacturing Co. Ltd. had the most positive impact on performance. Relative exposure to UnitedHealth Group Inc., Berkshire Hathaway Inc. and Marsh & McLennan Cos. Inc. was negative for performance.
At the sector level, stock selection in information technology and industrials was positive for performance. Underweight exposure to information technology and overweight exposure to health care had a negative impact on performance.
Currency effects had a positive impact on performance.
Portfolio activity
The sub-advisor sold Johnson & Johnson, HF Sinclair Corp. and Edenred SE.
Outlook
The sub-advisor favours attractively valued global companies whose performance is not driven by macroeconomic events.